Protective Actions of PPAR-γ Activation in Renal Endothelium

Protective Actions of PPAR-γ Activation in Renal Endothelium

Renal endothelial damage is pivotal in the initiation and progression of renal disease. Damaged renal endothelium may be regenerated through proliferation of local endothelium and circulation-derived endothelial progenitor cells. Activation of the PPAR-γ-receptors present on endothelial cells affec...

Full description

Bibliographic Details
Main Authors:	Peter E. Westerweel, Marianne C. Verhaar
Format:	Article
Language:	English
Published:	Hindawi Limited 2008-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2008/635680

Similar Items

The Role of PPARs in the Endothelium: Implications for Cancer Therapy
by: David Bishop-Bailey, et al.
Published: (2008-01-01)

Activators of PPARγ antagonize protection of cardiac myocytes by endothelin-1
by: Ehara, Natsuhiko
Published: (2011)

PPARγ, neuroinflammation, and disease
by: Mrak Robert E, et al.
Published: (2004-05-01)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01)

PPARγ is dispensable for clear cell renal cell carcinoma progression
by: Danielle J. Sanchez, et al.
Published: (2018-08-01)

PGC-1α Protects against Hepatic Ischemia Reperfusion Injury by Activating PPARα and PPARγ and Regulating ROS Production
by: Chaoqun Wang, et al.
Published: (2021-01-01)

GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury
by: Khrystyna Platko, et al.
Published: (2019-09-01)

PPAR-γ in the Cardiovascular System
by: Sheng Zhong Duan, et al.
Published: (2008-01-01)

Nutraceuticals as Ligands of PPARγ
by: Meera Penumetcha, et al.
Published: (2012-01-01)

PPARγ and Cognitive Performance
by: Michele d’Angelo, et al.
Published: (2019-10-01)

PPARγ maintains the metabolic heterogeneity and homeostasis of renal tubulesResearch in context
by: Zhongshi Lyu, et al.
Published: (2018-12-01)

Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia
by: O. Samuelsson, et al.
Published: (2013-01-01)

To Live or to Die: Prosurvival Activity of PPARγ in Cancers
by: Y. Lynn Wang, et al.
Published: (2008-01-01)

The Protective Effect of Apigenin on Myocardial Injury in Diabetic Rats mediating Activation of the PPAR-γ Pathway
by: Umesh B. Mahajan, et al.
Published: (2017-04-01)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex.
by: Justin A Lemkul, et al.
Published: (2015-01-01)

Structural Basis for the Regulation of PPARγ Activity by Imatinib
by: Jun Young Jang, et al.
Published: (2019-10-01)

Transcriptional activity of PPARγ in primary human adipocytes
by: Sauma, Lilian
Published: (2009)

Interplay between PPARγ and inflammasome activation in macrophages
by: Da-ChunLin, et al.
Published: (2013)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01)

Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs
by: Zhiyuan Niu, et al.
Published: (2017-10-01)

A Novel Splicing Variant of Peroxisome Proliferator-Activated Receptor-γ (Pparγ1sv) Cooperatively Regulates Adipocyte Differentiation with Pparγ2.
by: Yasuhiro Takenaka, et al.
Published: (2013-01-01)

Role of PPAR[gamma] and retinol binding protein 7 in the vascular endothelium
by: Woll, Addison Wayne
Published: (2017)

1,8-Cineole Ameliorates LPS-Induced Vascular Endothelium Dysfunction in Mice via PPAR-γ Dependent Regulation of NF-κB
by: Ke-Gang Linghu, et al.
Published: (2019-03-01)

Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in human hepatocytes.
by: Alexandra Rogue, et al.
Published: (2011-01-01)

Peroxisome Proliferator-Activated Receptor γ (PPARγ)-Independent Antitumor Effect of Thiazolidinediones
by: Wei, Shuo
Published: (2009)

The Role of Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) in Seizure and Neuronal Excitability
by: Fang-LiangChu, et al.
Published: (2016)

Defining a conformational ensemble that directs activation of PPARγ
by: Ian M. Chrisman, et al.
Published: (2018-05-01)

Effects of the PPAR-γ Agonist Rosiglitazone on Renal Haemodynamics and the Renin-Angiotensin System in Diabetes
by: M Cecilia Lansang, et al.
Published: (2006-09-01)

Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator
by: Yuki Hamano, et al.
Published: (2011-09-01)

Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptors.
by: Li-Song Zhang, et al.
Published: (2012-01-01)

PPARα and PPARγ as main regulators of fatty acid metabolism
by: Mirosław Kucharski, et al.
Published: (2018-10-01)

New Transcriptional Reporters to Quantify and Monitor PPARγ Activity
by: Séverine A. Degrelle, et al.
Published: (2017-01-01)

Identification of an irreversible PPARγ antagonist with potent anticancer activity
by: Youyi Peng, et al.
Published: (2020-12-01)

Analysis of <i>PPARγ</i> Signaling Activity in Psoriasis
by: Vladimir Sobolev, et al.
Published: (2021-08-01)

PPARγ in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2012-01-01)

Effects of PPARγ Ligands on Leukemia
by: Yoko Tabe, et al.
Published: (2012-01-01)

Prostaglandins as PPARγ Modulators in Adipogenesis
by: Ko Fujimori
Published: (2012-01-01)

PPARγ et homéostasie intestinale
by: Fumery, Mathurin
Published: (2018)

Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator
by: Xinni Xie, et al.
Published: (2017-05-01)

PPARα and PPARγ activators suppress the monocyte-macrophage apoB-48 receptor1
by: Go Haraguchi, et al.
Published: (2003-06-01)

Cannot write session to /tmp/vufind_sessions/sess_ip25br0370gjpb0907v0hi00jt